Predicting <i>In Vivo</i> Efficacy from <i>In Vitro</i> Data: Quantitative Systems Pharmacology Modeling for an Epigenetic Modifier Drug in CancerMehdi Bouhaddou, Antje‐Christine Walz|Clinical and Translational Science|2019Cited by 28
An alternative nonclinical approach to support the first-in-human clinical trial of a T-cell bispecific targeting EGFRvIIIElisabeth Husar, Antje‐Christine Walz, Angélique Augustin et al.|Journal of Pharmaceutical Sciences|2025Cited by 0